AZD4512
ALLight D9891C00001
Phase 2 small_molecule active
Quick answer
AZD4512 for B-cell acute lymphoblastic leukemia (B-ALL) is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- B-cell acute lymphoblastic leukemia (B-ALL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active